Page 4 - Yangshi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yangshi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yangshi Today - Breaking & Trending Today

Everest Medicines Initiates Submission of New Drug Application in Singapore for Sacituzumab Govitecan-Hziy for the Treatment of Metastatic Triple-Negative Breast Cancer


Share this article
Share this article
SHANGHAI, Jan. 6, 2021 /PRNewswire/ Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, announced today that it has initiated the submission of a New Drug Application (NDA) to the Health Sciences Authority (HSA) of Singapore for sacituzumab govitecan-hziy for the treatment of patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease.
Breast Cancer is Singapore s number one leading cause of cancer death in women and TNBC accounts for 15-20% of all breast cancer in Singapore. This milestone marks the first of a series of planned NDA submissions for sacituzumab govitecan-hziy in Everest s licensed territory, which also includes Greater China, South Korea, and certain addi ....

South Korea , Asia Pacj Clin , Sacituzumab Govitecan Hziy , Edmond Lococo , Asia Pacific , Goding Sauer , Kerry Blanchard , Darcie Robinson , National Cancer Database , Health Sciences Authority , Greater China , New Drug , Southeast Asian , Chief Medical Officer , About Triple Negative Breast , Negative Breast Cancer , Everest Medicines , National Cancer , Natl Cancer Inst , Pacj Clin Oncol , Cancer Res Treat , தெற்கு கொரியா , எட்மண்ட் லோகோகோ , ஆசியா பெஸிஃபிக் , கடவுளே சாவர் , கெர்ரி பிளான்சார்ட் ,